These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 3449135

  • 1. Our experience with combined hemodialysis-hemoperfusion treatment in chronic uremia.
    Splendiani G, Albano V, Tancredi M, Daniele M, Pignatelli F.
    Biomater Artif Cells Artif Organs; 1987; 15(1):175-81. PubMed ID: 3449135
    [Abstract] [Full Text] [Related]

  • 2. Improvement of continuous arteriovenous hemofiltration (CAVH) and hemofiltration (HF) efficiency by adding hemoperfusion (HP).
    Marangoni R, Civardi F, Masi F, Avanzi C, Savino R, Manfredi A, Cimino R.
    Biomater Artif Cells Artif Organs; 1990; 18(4):541-8. PubMed ID: 2285819
    [Abstract] [Full Text] [Related]

  • 3. The optimal timing of hemoperfusion component in combined hemodialysis-hemoperfusion treatment for uremic toxins removal.
    Li J, Li D, Xu Y, Wang A, Xu C, Yu C.
    Ren Fail; 2015 Feb; 37(1):103-7. PubMed ID: 25421427
    [Abstract] [Full Text] [Related]

  • 4. Use of combined hemodialysis/hemoperfusion in chronic uremia.
    Stefoni S, Feliciangeli G, Colì L, Prandini R, Bonomini V.
    Contrib Nephrol; 1982 Feb; 29():123-32. PubMed ID: 6804167
    [Abstract] [Full Text] [Related]

  • 5. Multicentric experience with combined hemodialysis/hemoperfusion in chronic uremia.
    Bonomini V, Stefoni S, Casciani CU, Taccone Gallucci M, Albertazzi A, Cappelli P, Mioli V, Boggi R, Mastrangelo F, Rizzelli S.
    Contrib Nephrol; 1982 Feb; 29():133-42. PubMed ID: 7075212
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Removal of endogenous middle molecules by hemoperfusion.
    Asaba H, Bergström J, Fürst P, Gunnarsson B, Neuhauser M, Oulès R, Yahiel V.
    Artif Organs; 1979 May; 3(2):132-6. PubMed ID: 533396
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Evaluation of a new coated charcoal for hemoperfusion in uremia.
    Stefoni S, Feliciangeli G, Coli L, Bonomini V.
    Int J Artif Organs; 1979 Nov; 2(6):320-3. PubMed ID: 511374
    [Abstract] [Full Text] [Related]

  • 11. Hemoperfusion with uncoated amberlite XE-336 resin in normal and uremic dogs.
    Rosenbaum JL, Kramer MS, Raja R.
    Nephron; 1978 Nov; 21(1):27-37. PubMed ID: 662054
    [Abstract] [Full Text] [Related]

  • 12. Effect of the Combination of Hemodialysis and Hemoperfusion on Clearing Advanced Glycation End Products: A Prospective, Randomized, Two-Stage Crossover Trial in Patients Under Maintenance Hemodialysis.
    Zhang Y, Mei CL, Rong S, Liu YY, Xiao GQ, Shao YH, Kong YZ.
    Blood Purif; 2015 Nov; 40(2):127-32. PubMed ID: 26160062
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The use of hemoperfusion as an adjunct to hemodialysis.
    Trafford A, Ireland R, Evans R.
    Artif Organs; 1979 Aug; 3(3):249-52. PubMed ID: 533415
    [Abstract] [Full Text] [Related]

  • 18. Adsorption of Protein-Bound Uremic Toxins Using Activated Carbon through Direct Hemoperfusion in vitro.
    Yamamoto S, Ito T, Sato M, Goto S, Kazama JJ, Gejyo F, Narita I.
    Blood Purif; 2019 Aug; 48(3):215-222. PubMed ID: 31055586
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.